SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-009279
Filing Date
2019-06-17
Accepted
2019-06-17 07:59:36
Documents
17
Period of Report
2019-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 33358
2 ex99-1.htm EX-99.1 12778
3 ex99-2.htm EX-99.2 20822
4 ex99-3.htm EX-99.3 85932
5 ex99-1_001.jpg GRAPHIC 93862
6 ex99-1_002.jpg GRAPHIC 204428
7 ex99-1_003.jpg GRAPHIC 139473
8 ex99-1_004.jpg GRAPHIC 109051
9 ex99-1_005.jpg GRAPHIC 146991
10 ex99-1_006.jpg GRAPHIC 122687
11 ex99-1_007.jpg GRAPHIC 96771
12 ex99-1_008.jpg GRAPHIC 123703
13 ex99-1_009.jpg GRAPHIC 113927
14 ex99-1_010.jpg GRAPHIC 138498
15 ex99-1_011.jpg GRAPHIC 119171
16 ex99-1_012.jpg GRAPHIC 76794
17 ex99-2_001.jpg GRAPHIC 6483
  Complete submission text file 0001493152-19-009279.txt   2210098
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 19900491
SIC: 2834 Pharmaceutical Preparations